|
MORE DETAILS
|
Home
About us
Testimonials
Events
Useful Reading
Companies
Independents
Services
Special offers
Job Adverts
Twittering
Webcasts
Starting out
|
|
|
ATTENDEES
Alison McIntosh
Andy Scott
Anna Palmer
Cate Foster
Charlie Grieve
Christina Mackins
Christine Deakin
Christine Drewienkiewicz
Claire Duffy
Elif Fincanci-Smith
Gill Gibbons
Guy Jeynes-Ellis
Jo Whelan
Jules McRobbie
Julie Bowdler
Julie Van Onselen
Liz Wager
Louise Alder
Marian East
Peter Llewellyn
Raji Nandipati
Reghu Venkatesan
Sally Tranter
Steve Dunn
Steven Gray
Stuart Wakelin
Sue Libretto
|
|
|
This informal initiative, led by Peter Llewellyn of NetworkPharma, encourages networking and dialogue amongst individuals working in and around specialist medical education, medical communications and medical publishing businesses primarily based in the UK.
Please help spread the word and sign up for our weekly newsletter by emailing Peter Llewellyn.
|
|
|
Join the MedComms Forum LinkedIn Group.
The Group is open to all and intended to serve as a catalyst for wider debate and dialogue about the legitimate role of medical communications and the role of the global pharmaceutical industry in delivering optimal healthcare management to all patients.
|
|
|
Related Sites
|
|
EVENING BRIEFING - 14 MAY 2009 - OXFORD
|
GPP2: New Good Publication Practice
Good Publication Practice (GPP) is the first port-of-call for publication professionals looking for guidance about publishing clinical and preclinical information, especially when this information has been gathered, analysed, or written with pharmaceutical, biotech or medical device company support.
But consider this: the first ideas for GPP were formed during a retreat of the Council of Biology Editors (now Council of Science Editors or CSE) a decade ago. With all that has happened since, it’s safe to say the time is right for GPP2: a new, revised version of Good Publication Practice.
GPP2 has been developed by a steering committee of International Society for Medical Publication Professionals (ISMPP) members, coordinated by Chris Graf. A very far-reaching consultation process has been undertaken and the results were presented for the first time in Philadelphia at the 5th Annual Meeting of ISMPP, 20-22 April 2009.
This Briefing meeting gave us the chance to hear about this important initiative directly from Chris Graf who led the consultation process, while it is still very hot news. A summary of his presentation, recorded earlier in the day in Oxford, is provided below as a webcast from NetworkPharma.tv.
|
GPP2: New Good Publication Practice
Recorded 14 May 2009, Oxford
From NetworkPharma.tv - Chris explains the background, purpose and future plans for GPP2.
[VIEW WEBCAST - opens new window]
|
To make sure you're included in announcements about future events just email Peter Llewellyn, if you haven't already done so, to register your interest.
|
|
|
